Prevention and treatment of portal vein thrombosis after splenectomy or combined devascularization with anticoagulant drugs
10.3760/cma.j.issn.1673-4203.2019.02.014
- VernacularTitle:抗凝药物防治脾切除或联合断流术后门脉系统血栓的研究进展
- Author:
Baohuan ZHOU
1
;
Guoqing JIANG
Author Information
1. 大连医科大学 116044
- Keywords:
Portal system;
Thromboembolism;
Liver cirrhosis;
Splenectomy;
Anticoagulants
- From:
International Journal of Surgery
2019;46(2):131-136
- CountryChina
- Language:Chinese
-
Abstract:
Portal vein system thrombosis (PVST) is a common complication in patients after open or laparoscopic splenectomy or combined with devascularization.It may endanger the health of the patients after surgery and even potentially endanger the patient's life in severe cases.The formation and development of PVST is affected by many factors,and the correct use of anticoagulant drugs play a vital role in the prevention and treatment of PVST in postoperative patients with cirrhotic portal hypertension.This article discusses the advances in research on the prevention and treatment of PVST after open or laparoscopic splenectomy or combined with devascularization with anticoagulant drugs,and reviews the current anticoagulant properties and recommends of anticoagulant therapy,further guides the use of clinical anticoagulant drugs to reduce the incidence of PVST and improve the quality of life in patients with such surgery.
